SARS-CoV-2 Spike Protein (RBD) Fusion Protein

<strong>SARS-CoV-2 Spike Protein(RBD) Fusion Protein</strong>_x000D_ <strong>Catalog number:</strong> B2015484_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 25 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 48 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20¬∞C_x000D_ <strong>Keywords:</strong> 2019-nCOV Spike Protein(RBD) Fusion Protein_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MŒ©-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Kang YF, Sun C, Zhuang Z, Yuan RY, Zheng Q, Li JP, Zhou PP, Chen XC, Liu Z, Zhang X, Yu XH, Kong XW, Zhu QY, Zhong Q, Xu M, Zhong NS, Zeng YX, Feng GK, Ke C, Zhao JC, Zeng MS. Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates ACS Nano. 2021 Feb 23;15(2):2738-2752._x000D_ 2: Pillay TS. Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein J Clin Pathol. 2020 Jul;73(7):366-369._x000D_ 3: Cui Z, Liu P, Wang N, Wang L, Fan K, Zhu Q, Wang K, Chen R, Feng R, Jia Z, Yang M, Xu G, Zhu B, Fu W, Chu T, Feng L, Wang Y, Pei X, Yang P, Xie XS, Cao L, Cao Y, Wang X. Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron Cell. 2022 Mar 3;185(5):860-871.e13._x000D_ 4: Kordyukova LV, Shanko AV. COVID-19: Myths and Reality Biochemistry (Mosc). 2021 Jul;86(7):800-817._x000D_ 5: Kalathiya U, Padariya M, Fahraeus R, Chakraborti S, Hupp TR. Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages Biomolecules. 2021 Feb 17;11(2):297._x000D_ 6: Silwal AP, Thennakoon SKS, Arya SP, Postema RM, Jahan R, Phuoc CMT, Tan X. DNA aptamers inhibit SARS-CoV-2 spike-protein binding to hACE2 by an RBD- independent or dependent approach Theranostics. 2022 Jul 18;12(12):5522-5536._x000D_ 7: Chen YL, Lin JJ, Ma H, Zhong N, Xie XX, Yang Y, Zheng P, Zhang LJ, Jin T, Cao MJ. Screening and Characterization of Shark-Derived VNARs against SARS-CoV-2 Spike RBD Protein Int J Mol Sci. 2022 Sep 18;23(18):10904._x000D_ 8: Gerez G, Martinez J, Steinbrugger C, Bouanich S, Dimino J, Piegay C, Combe M, Berthier F, Daniel S. Impact of SARS-CoV-2 RBD Mutations on the Production of a Recombinant RBD Fusion Protein in Mammalian Cells Biomolecules. 2022 Aug 24;12(9):1170._x000D_ 9: Phan A, Avila H, MacKay JA. Biomimetic SARS-CoV-2 Spike Protein Nanoparticles Biomacromolecules. 2023 May 8;24(5):2030-2041._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/34497376">10: Du L, Yang Y, Zhang X. Neutralizing antibodies for the prevention and treatment of COVID-19 Cell Mol Immunol. 2021 Oct;18(10):2293-2306. </a>_x000D_ _x000D_ <strong>Products Related to SARS-CoV-2 Spike Protein(RBD) Fusion Protein can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>